Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
Location status: Recruiting
Location contact
Jorge A Rodriguez, MD
CONTACT
NCT Number: NCT06283992
The goal of this clinical trial is to learn about digital literacy training in adult, Latino patient with type II diabetes. The main question it aims to answer is: Can providing digital literacy training during a hospital admission can help patients with their after-hospital care by using the patient portal and telehealth? Participants will receive digital literacy training by a digital navigator that focuses on the main patient portal functions. Researchers will compare patients who receive digital literacy training to those who receive standard of care (educational sheet) to see if it impacts their use of the patient portal after discharge.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02120, United States
Location status: Recruiting
Jorge A Rodriguez, MD
CONTACT
Latinos have the second-highest age-adjusted prevalence and among the highest incidence of diabetes. Latinos also experience worse glycemic control and diabetes-related complications, including diabetic retinopathy and chronic renal disease. These findings are concerning since Latinos are the largest minority group in the U.S and will account for 25% of the population by 2045.
Digital tools, like patient portals and telemedicine, offer an opportunity to address some of the challenges that lead to these disparities, especially during care transitions. However, Latinos, especially those who are Spanish-speaking are less likely to use digital health tools. Findings from previous health information technology work have highlighted barriers, including 1) digital access and literacy, 2) interface usability, 3) privacy, and 4) patient preference. One promising intervention to address digital literacy gaps is the use digital navigators.
This study aims are to assess a digital health navigation intervention focused on increasing patient portal use after discharge among Latino patients with type II diabetes admitted to the general medicine inpatient floor.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1:1 educational support at the bedside about the functions of the patient portal and telehealth that can help with care transitions.
Time frame: 30 days post-discharge
Number of participants with at least 1 login to the portal in the 30 days after discharge
Time frame: 30 days post-discharge
Proportion of participants that perform distinct portal functions (sending messages, requesting refill)
Time frame: 30 days post-discharge
Proportion of participants that complete a telehealth visit during post-discharge period
Time frame: 30 days post-discharge
Proportion of participants that are re-admitted within 30 days after discharge
Contact information is provided by the study sponsor or research team.
Brigham and Women's Hospital
Other
Digital Health Navigation for Latino Patients With Type II Diabetes: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07318207
Diabetes Mellitus, Diabetes Mellitus, Type 2
Lexington, Kentucky, United States
View Trial DetailsNCT06730113
Body Weight, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT07032844
Diabetes Mellitus, Diabetes Mellitus, Type 2
Birmingham, Alabama, United States
View Trial DetailsNCT06067399
Diabetes Mellitus, Diabetes Mellitus, Type 2
Al Khārjah, Egypt
View Trial Details